THE_HORIZONS_CLINIC_AFRIC - Accounts


Company Registration No. SC345629 (Scotland)
THE HORIZONS CLINIC AFRICA LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 JULY 2019
PAGES FOR FILING WITH REGISTRAR
THE HORIZONS CLINIC AFRICA LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
THE HORIZONS CLINIC AFRICA LIMITED
BALANCE SHEET
AS AT 29 JULY 2019
29 July 2019
- 1 -
2019
2018
Notes
£
£
£
£
Fixed assets
Investments
2
1,980
1,980
Current assets
Debtors
4
3,103,505
3,014,951
Cash at bank and in hand
7,882
92,955
3,111,387
3,107,906
Creditors: amounts falling due within one year
5
(13,371)
(9,890)
Net current assets
3,098,016
3,098,016
Total assets less current liabilities
3,099,996
3,099,996
Capital and reserves
Called up share capital
6
59,687
59,687
Share premium account
3,090,313
3,090,313
Profit and loss reserves
(50,004)
(50,004)
Total equity
3,099,996
3,099,996

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 29 July 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 20 July 2020 and are signed on its behalf by:
Professor J M O N'Dow
Director
Company Registration No. SC345629
THE HORIZONS CLINIC AFRICA LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 JULY 2019
- 2 -
1
Accounting policies
Company information

The Horizons Clinic Africa Limited is a private company limited by shares incorporated in Scotland. The registered office is 13 Queen's Road, ABERDEEN, AB15 4YL.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Fixed asset investments

Interests in subsidiaries, are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.3
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand.

1.4
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are measured at transaction price including transaction costs.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors and loans from fellow group companies, are recognised at transaction price.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less.

THE HORIZONS CLINIC AFRICA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 29 JULY 2019
1
Accounting policies
(Continued)
- 3 -
1.5
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2
Fixed asset investments
2019
2018
£
£
Investments
1,980
1,980
Movements in fixed asset investments
Shares in group undertakings
£
Cost or valuation
At 30 July 2018 & 29 July 2019
1,980
Carrying amount
At 29 July 2019
1,980
At 29 July 2018
1,980
3
Subsidiaries

Details of the company's subsidiaries at 29 July 2019 are as follows:

Name of undertaking
Registered
Nature of business
Class of
% Held
office
shares held
Direct
Indirect
The Horizons Clinic (Gambia) Limited
Gambia
Provision of hospital and medical facilities
Ordinary
99.00
0
THE HORIZONS CLINIC AFRICA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 29 JULY 2019
- 4 -
4
Debtors
2019
2018
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
-
1,199,941
Other debtors
1,815,010
1,815,010
1,815,010
3,014,951
2019
2018
Amounts falling due after more than one year:
£
£
Amounts owed by group undertakings
1,288,495
-
Total debtors
3,103,505
3,014,951
5
Creditors: amounts falling due within one year
2019
2018
£
£
Trade creditors
10,871
7,390
Other creditors
2,500
2,500
13,371
9,890
6
Called up share capital
2019
2018
£
£
Ordinary share capital
Issued and not fully paid
312,500 Ordinary A shares of 1p each
3,125
3,125
4,687,500 Ordinary B shares of 1p each
46,875
46,875
968,700 Ordinary C shares of 1p each
9,687
9,687
59,687
59,687

Ordinary A shares - 312,500 shares have been issued and fully paid.

Ordinary B shares - 4,687,500 shares have been issued and fully paid

Ordinary C shares - 968,700 shares have been issued which have not been fully paid.

THE HORIZONS CLINIC AFRICA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 29 JULY 2019
- 5 -
7
Related party transactions

During the year the company made payments of £88,553 (2018 - £261,681) on behalf of the subsidiary. Included within other debtors at the year end was a balance due from the subsidiary undertaking of £1,288,495 (2018 - £1,199,942).

8
Parent company

The company was controlled by Horizons Trust (Gambia) Limited, a company limited by guarantee and incorporated in Gambia. This company is controlled by its subscribers.

2019-07-292018-07-30false20 July 2020CCH SoftwareCCH Accounts Production 2020.100No description of principal activityProfessor J M O N'DowO OjoMr W KeathleyMs A PizziconiMr H BaldehPinsent Masons Secretarial LimitedSC3456292018-07-302019-07-29SC3456292019-07-29SC3456292018-07-29SC345629core:CurrentFinancialInstrumentscore:WithinOneYear2019-07-29SC345629core:CurrentFinancialInstrumentscore:WithinOneYear2018-07-29SC345629core:CurrentFinancialInstruments2019-07-29SC345629core:CurrentFinancialInstruments2018-07-29SC345629core:ShareCapital2019-07-29SC345629core:ShareCapital2018-07-29SC345629core:SharePremium2019-07-29SC345629core:SharePremium2018-07-29SC345629core:RetainedEarningsAccumulatedLosses2019-07-29SC345629core:RetainedEarningsAccumulatedLosses2018-07-29SC345629core:ShareCapitalOrdinaryShares2019-07-29SC345629core:ShareCapitalOrdinaryShares2018-07-29SC345629bus:Director12018-07-302019-07-29SC345629core:Subsidiary12018-07-302019-07-29SC345629core:Subsidiary112018-07-302019-07-29SC345629core:Non-currentFinancialInstruments2019-07-29SC345629core:WithinOneYear2019-07-29SC345629core:WithinOneYear2018-07-29SC345629bus:PrivateLimitedCompanyLtd2018-07-302019-07-29SC345629bus:SmallCompaniesRegimeForAccounts2018-07-302019-07-29SC345629bus:FRS1022018-07-302019-07-29SC345629bus:AuditExemptWithAccountantsReport2018-07-302019-07-29SC345629bus:Director22018-07-302019-07-29SC345629bus:Director32018-07-302019-07-29SC345629bus:Director42018-07-302019-07-29SC345629bus:Director52018-07-302019-07-29SC345629bus:CompanySecretary12018-07-302019-07-29SC345629bus:FullAccounts2018-07-302019-07-29xbrli:purexbrli:sharesiso4217:GBP